A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors

Clinical trial NCT06245330 · RECRUITING

Trial details

NCT number: NCT06245330
Sponsor: Ascentawits Pharmaceuticals, Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Pancreatic Cancer

Start date: 2022-07-07
Primary completion: 2027-08-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.